BPG is committed to discovery and dissemination of knowledge
Cited by in F6Publishing
For: de Araújo RSA, Carmo JDODS, de Omena Silva SL, Costa da Silva CRA, Souza TPM, Mélo NBD, Bourguignon J, Schmitt M, Aquino TMD, Rodarte RS, Moura ROD, Barbosa Filho JM, Barreto E, Mendonça-junior FJB. Coumarin Derivatives Exert Anti-Lung Cancer Activity by Inhibition of Epithelial–Mesenchymal Transition and Migration in A549 Cells. Pharmaceuticals 2022;15:104. [DOI: 10.3390/ph15010104] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 2.0] [Reference Citation Analysis]
Number Citing Articles
1 Zhang R, Li S, Lan J, Li C, Du X, Dong W, Yu Q, Wang D. CNTN-1 Upregulation Induced by Low-Dose Cisplatin Promotes Malignant Progression of Lung Adenocarcinoma Cells via Activation of Epithelial-Mesenchymal Transition. Front Genet 2022;13:891665. [PMID: 35711928 DOI: 10.3389/fgene.2022.891665] [Reference Citation Analysis]
2 Xue X, Liu Y, Qu L, Fan C, Ma X, Ouyang P, Fan D. Ginsenoside Rh3 Inhibits Lung Cancer Metastasis by Targeting Extracellular Signal-Regulated Kinase: A Network Pharmacology Study. Pharmaceuticals (Basel) 2022;15:758. [PMID: 35745677 DOI: 10.3390/ph15060758] [Reference Citation Analysis]